Ciprofloxacin for the Prevention of Postoperative Recurrence in Patients with Crohnʼs Disease: A Randomized, Double-blind, Placebo-controlled Pilot Study
The commensal bacterial flora plays a critical role in postoperative recurrence of Crohn’s disease (CD). We conducted a randomized, double-blind, placebo-controlled 6 months pilot trial of ciprofloxacin for the prevention of endoscopic recurrence in patients with CD who underwent surgery
